Last quarter (Q4 2023), InnoCan Pharma's total revenue was $4.89M, an increase of 333.78% from the same quarter last year. In Q4, InnoCan Pharma's net income was $-883.00K. See InnoCan Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 13.66M	$ 13.66M	$ 2.56M	$ 196.00K	$ 8.00K	$ 0.00
Cost of Revenue	$ 1.68M	$ 1.68M	$ 452.00K	$ 75.00K	$ 5.00K	$ 0.00
Gross Profit	$ 11.98M	$ 11.98M	$ 2.11M	$ 121.00K	$ 3.00K	$ 0.00
Operating Expense	$ 15.78M	$ 15.78M	$ 8.37M	$ 7.60M	$ 4.73M	$ 3.00M
Operating Income	$ -3.80M	$ -3.80M	$ -6.27M	$ -7.48M	$ -4.72M	$ -3.00M
Net Non Operating Interest Income Expense	$ 102.00K	$ 23.00K	$ -2.00K	$ -13.00K	$ -8.00K	$ -334.00K
Other Income Expense	$ 337.00K	$ 258.00K	$ -2.79M	$ 2.31M	$ -5.22M	-
Pretax Income	$ -4.03M	$ -4.03M	$ -3.89M	$ -10.09M	$ -9.95M	$ -3.33M
Tax Provision	$ 214.00K	$ 214.00K	$ 1.00K	-	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -4.70M	$ -4.70M	$ -3.76M	$ -10.13M	$ -9.95M	$ -3.33M
Basic EPS	$ -0.02	$ -0.02	$ -0.02	$ -0.05	$ -0.06	$ -0.03
Diluted EPS	$ -0.02	$ -0.02	$ -0.02	$ -0.05	$ -0.06	$ -0.03
Basic Average Shares	$ 1.03B	$ 257.00M	$ 248.95M	$ 224.54M	$ 162.02M	$ 120.64M
Diluted Average Shares	$ 1.03B	$ 257.00M	$ 248.95M	$ 224.54M	$ 162.02M	$ 120.64M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 17.46M	$ 17.46M	$ 8.82M	-	$ 4.73M	$ 3.00M
Net Income From Continuing And Discontinued Operation	$ -4.70M	$ -4.70M	$ -3.76M	$ -10.13M	$ -9.95M	$ -3.33M
Normalized Income	$ -2.96M	$ -2.96M	$ -2.86M	$ -7.42M	$ -4.73M	$ -3.33M
Interest Expense	-	-	-	-	$ 8.00K	$ 334.00K
EBIT	$ -4.03M	$ -4.03M	$ -3.89M	$ -10.08M	$ -9.95M	$ -3.00M
EBITDA	$ -4.00M	$ -4.00M	$ -3.85M	$ -10.04M	$ -9.90M	$ -2.98M

Currency in USD

InnoCan Pharma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing